ShangPharma Corp. (SHP) Misses Q2 EPS by 9c; Revises FY12 Sales Outlook

August 20, 2012 6:28 AM EDT Send to a Friend
Get Alerts SHP Hot Sheet
Trade SHP Now!
Join SI Premium – FREE
ShangPharma Corp. (NYSE: SHP) reported Q2 EPS of $0.11, $0.09 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $31.8 million versus the consensus estimate of $32.84 million.

ShangPharma Corp. sees FY2012 revenue of $131.7-136.2 million, versus the consensus of $134.19 million.

For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment